Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer
Clinical trial NCT01088620 · SUSPENDED
Trial details
- NCT number
- NCT01088620
- Sponsor
- WiSP Wissenschaftlicher Service Pharma GmbH
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2013-01-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.